Bev Acreman Is Appointed Commercial Director of F1000
F1000, a provider of services to biomedical researchers to support the discovery, writing and publication of new scientific findings, has appointed Bev Acreman as Commercial Director.
London, United Kingdom, January 26, 2016 (Newswire.com) - Bev, who will take up the post at the beginning of April, was formerly Vice President of Marketing & Sales, Open Research, at Springer Nature – a global research, educational and professional publisher.
At Springer Nature, part of Bev’s role included a focus on collaborating with Chinese funders and universities to build a solid infrastructure and understanding of Open Access in this hugely important scientific market.
She has spoken at Chinese conferences organised by the Chinese Academy of Sciences (CAS) and Chinese Association for Science and Technology (CAST). She also set up and ran the inaugural Open Access Asia (OASPA) conference in Bangkok in 2014.
Prior to that, Bev headed up the commercial division at the first open access publisher, BioMed Central, where she built up its international sales, marketing and customer service teams
Bev is currently on the board of UKSG. She has served as a committee chair for the STM Association and recently joined the Directory of Open Access Journals’ (DOAJ) advisory committee.
Rebecca Lawrence, managing director of F1000, said: “Bev has extensive experience in marketing and sales, both in open access publishing and in the development of tools to help researchers manage references and ultimately write articles.
“We are delighted to welcome her to F1000 where she will play a key role in helping us to drive much-needed change in the way that new findings are shared and researchers are evaluated.”
Bev said: “It is an exciting time to be joining F1000: there are major changes underway in the communication of scientific research and F1000 is determined to lead these changes – through post publication peer review in F1000Research, the new F1000Workspace, and the respected F1000Prime article recommendations by the F1000 Faculty.”
Ends
For more information:
Andrew Baud, Tala (on behalf of F1000), +44 (0) 20 3397 3383 or +44 (0) 7775 715775
Notes to editors
F1000 was founded by science publishing entrepreneur Vitek Tracz, a passionate advocate of open access publishing and open science. F1000 is a community of more than 11,000 biomedical experts who help scientists to discover, discuss and publish research. F1000 offers the following services:
F1000Research - an open science publishing platform for life scientists that offers immediate publication and transparent peer review, avoiding editorial bias and ensuring the inclusion of all source data.
F1000Prime - a service which identifies and recommends important articles in biology and medical research publications.
F1000Workspace - a new research collaboration, reference management and authoring platform for scientists.